Position Statement and Practice Guidelines on the Use of Multi-Dose Activated Charcoal in the Treatment of Acute Poisoning

REFERENCES

• Chyka P A, Holley J E, Mandrell J D, Sugathan P. Correlation of drug pharmacokinetics and effectiveness of multiple-dose activated charcoal therapy. Ann Emerg Med 1995; 25: 356–362
   PubMed Web of Science ®Google Scholar
• Arimori K, Nakano M. Accelerated clearance of intravenously administered theophylline and phenobarbital by oral doses of activated charcoal in rats. A possibility of the intestinal dialysis. J Pharmacobiodyn 1986; 9: 437–441
   PubMedGoogle Scholar
• Arimori K, Nakano M. The intestinal dialysis of intravenously administered phenytoin by oral activated charcoal in rats. J Pharmacobiodyn 1987; 10: 157–165
   PubMedGoogle Scholar
• Johnson D, Eppler J, Giesbrecht E, et al. Effect of multiple-dose activated charcoal on the clearance of high-dose intravenous aspirin in a porcine model. Ann Emerg Med 1995; 26: 569–574
   PubMed Web of Science ®Google Scholar
• Neuvonen P J, Elonen E. Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine and phenyl-butazone in man. Eur J Clin Pharmacol 1980; 17: 51–57
   PubMed Web of Science ®Google Scholar
• Neuvonen P J, Elonen E, Mattila M J. Oral activated charcoal and dapsone elimination. Clin Pharmacol Ther 1980; 27: 823–827
   PubMed Web of Science ®Google Scholar
• Karkkainen S, Neuvonen P J. Effect of oral charcoal and urine pH on dextropropoxyphene pharmacokinetics. Int J Clin Pharmacol Ther 1985; 23: 219–225
   Web of Science ®Google Scholar
• Park G D, Goldberg M J, Spector R, et al. The effects of activated charcoal on digoxin and digitoxin clearance. Drug Intell Clin Pharm 1985; 19: 937–941
   PubMedGoogle Scholar
• Reissell P, Manninen V. Effect of administration of activated charcoal and fibre on absorption, excretion and steady state blood levels of digoxin and digitoxin. Evidence for intestinal secretion of the glycosides. Acta Med Scand 1982; 668: 88–90
   Google Scholar
• Lalonde R L, Deshpande R, Hamilton P P, McLean W M, Greenway D C. Acceleration of digoxin clearance by activated charcoal. Clin Pharmacol Ther 1985; 37: 367–371
   PubMed Web of Science ®Google Scholar
• Arimori K, Kawano H, Nakano M. Gastrointestinal dialysis of disopyramide in healthy subjects. Int J Clin Pharmacol Ther Toxicol 1989; 27: 280–284
   PubMedGoogle Scholar
• Du Souich P, Caillé G, Larochelle P. Enhancement of nadolol elimination by activated charcoal and antibiotics. Clin Pharmacol Ther 1983; 33: 585–590
   PubMed Web of Science ®Google Scholar
• Berg M J, Berlinger W G, Goldberg M J, Spector R, Johnson G E. Acceleration of the body clearance of phenobarbital by oral activated charcoal. N Engl J Med 1982; 307: 642–644
   PubMed Web of Science ®Google Scholar
• Berg M J, Rose J Q, Wurster D E, Rahman S, Fincham R W. Schottelius DD. Effect of charcoal and sorbitol-charcoal suspension on the elimination of intravenous phenobarbital. Ther Drug Monit 1987; 9: 41–47
   PubMed Web of Science ®Google Scholar
• Frenia M L, Schauben J L, Wears R L, Karlix J L, Tucker C A, Kunisaki T A. Multiple-dose activated charcoal compared to urinary alkalinization for the enhancement of phenobarbital elimination. J Toxicol Clin Toxicol 1996; 34: 169–175
   PubMed Web of Science ®Google Scholar
• Mauro L S, Mauro V F, Brown D L, Somani P. Enhancement of phenytoin elimination by multiple-dose activated charcoal. Ann Emerg Med 1987; 16: 1132–1135
   PubMed Web of Science ®Google Scholar
• Rowden A M, Spoor J E, Bertino J S. The effect of activated charcoal on phenytoin pharmacokinetics. Ann Emerg Med 1990; 19: 1144–1147
   PubMed Web of Science ®Google Scholar
• Laufen H, Leitold M. The effect of activated charcoal on the bioavailability of pyroxicam in man. Int J Clin Pharmacol Ther 1986; 24: 48–52
   Web of Science ®Google Scholar
• Lockey D, Bateman D N. Effect of oral activated charcoal on quinine elimination. Br J Clin Pharmacol 1989; 27: 92–94
   PubMed Web of Science ®Google Scholar
• Karkkainen S, Neuvonen P J. Effect of oral charcoal and urine pH on sotalol pharmacokinetics. Int J Clin Pharmacol Ther 1984; 22: 441–446
   Web of Science ®Google Scholar
• Berlinger W G, Spector R, Goldberg M J, Johnson G F, Quee C K, Berg M J. Enhancement of theophylline clearance by oral activated charcoal. Clin Pharmacol Ther 1983; 33: 351–354
   PubMed Web of Science ®Google Scholar
• Ilkhanipour K, Yealy D M, Krenzelok E P. The comparative efficacy of various multiple-dose activated charcoal regimens. Am J Emerg Med 1992; 310: 298–300
   Google Scholar
• Mahutte C K, True R J, Michiels T M, Berman J M, Light R W. Increased serum theophylline clearance with orally administered activated charcoal. Am Rev Respir Dis 1983; 128: 820–822
   PubMed Web of Science ®Google Scholar
• Park G D, Radomski L, Goldberg M J, Spector R, Johnson G F, Quee C F. Effects of size and frequency of oral doses of charcoal on theophylline clearance. Clin Pharmacol Ther 1983; 34: 663–666
   PubMed Web of Science ®Google Scholar
• Park G D, Spector R, Goldberg M J, Johnson G F, Feldman R, Quee C K. Effect of the surface area of activated charcoal on theophylline clearance. J Clin Pharmacol 1984; 24: 289–292
   PubMed Web of Science ®Google Scholar
• Radomski L, Park g D, Goldberg M J, Spector R, Johnson G F, Quee C K. Model for theophylline overdose treatment with oral activated charcoal. Clin Pharmacol Ther 1984; 35: 402–408
   PubMed Web of Science ®Google Scholar
• Barone J A, Raia J J, Huang Y C. Evaluation of the effects of multiple-dose activated charcoal on the absorption of orally administered salicylate in a simulated toxic ingestion model. Ann Emerg Med 1988; 17: 34–37
   PubMed Web of Science ®Google Scholar
• Kirshenbaum L A, Mathews S C, Sitar D S, Tenenbein M. Does multiple-dose charcoal therapy enhance salicylate excretion?. Arch Intern Med 1990; 150: 1281–1283
   PubMed Web of Science ®Google Scholar
• Ho J L, Tierney M G, Dickinson G E. An evaluation of the effect of repeated doses of oral activated charcoal on salicylate elimination. J Clin Pharmacol 1989; 29: 366–369
   PubMed Web of Science ®Google Scholar
• Mayer A L, Sitar D S, Tenebein G M. Multiple-dose charcoal and whole-bowel irrigation do not increase clearance of absorbed salicylate. Arch Intern Med 1992; 152: 393–396
   PubMed Web of Science ®Google Scholar
• Laine K, Kivisto K T, Neuvonen P J. The effect of activated charcoal on the absorption and elimination of astemizole. Hum Exp Toxicol 1994; 13: 502–505
   PubMed Web of Science ®Google Scholar
• Neuvonen P J, Karkkainen S. Effects of charcoal, sodium bicarbonate, and ammonium chloride on chlorpropamide kinetics. Clin Pharmacol Ther 1983; 33: 386–393
   PubMed Web of Science ®Google Scholar
• Al-Shareef A, Buss D C, Shetty H GM, Ali N, Rout-ledge P A. The effect of repeated-dose activated charcoal on the pharmacokinetics of sodium valproate in healthy volunteers. Br J Clin Pharmacol 1997; 43: 109–111
   PubMed Web of Science ®Google Scholar
• Davis R L, Koup J R, Roon R A, Opheim K E, Smith A N. Effect of oral activated charcoal on tobramycin clearance. Antimicrob Agents Chemother 1988; 32: 274–275
   PubMed Web of Science ®Google Scholar
• Watson W A, Jenkins T C, Velasquez N, Schentag J J. Repeated oral doses of activated charcoal and the clearance of tobramycin, a non-absorbable drug. J Toxicol Clin Toxicol 1987; 25: 171–184
   PubMed Web of Science ®Google Scholar
• Davis R L, Roon R A, Koup J R, Smith A L. Effect of orally administered activated charcoal on vancomycin clearance. Antimicrob Agents Chemother 1987; 31: 720–722
   PubMed Web of Science ®Google Scholar
• Karkkainen S, Neuvonen P J. Pharmacokinetics of amitriptyline influenced by oral charcoal and urine pH. Int J Clin Pharmacol Ther 1986; 24: 326–332
   Web of Science ®Google Scholar
• Scheinin M, Virtanen R, Iisalo E. Effect of single and cnrepeated doses of activated charcoal on the pharmacokinetics of doxepin. Int J Clin Pharmacol Ther 1985; 23: 38–42
   Web of Science ®Google Scholar
• Goldberg M J, Park G D, Spector R, Fischer L J, Feldman R D. Lack of effect of oral activated charcoal on imipramine clearance. Clin Pharmacol Ther 1985; 38: 350–353
   PubMed Web of Science ®Google Scholar
• Crome P, Dawling S, Braithwaite R A, Masters J, Walkey R. Effect of activated charcoal on absorption of nortriptyline. Lancet 1977; 2: 1203–1205
   PubMed Web of Science ®Google Scholar
• Boldy D AR, Heath A, Ruddock S, Vale J A, Prescott L F. Activated charcoal for carbamazepine poisoning. Lancet 1987; 1: 1027
   PubMed Web of Science ®Google Scholar
• Montoya-Cabrera M A, Sauceda-Garcia J M, Escalante-Galindo P, Flores-Alvarez E, Ruiz-Gomez A. Carbamazepine poisoning in adolescent suicide attempters. Effectiveness of multiple-dose activated charcoal in enhancing carbamazepine elimination. Arch Med Res 1996; 27: 485–489
   PubMed Web of Science ®Google Scholar
• Neuvonen P J, Elonen E, Haapanen E J. Acute dapsone intoxication: Clinical findings and effect of oral charcoal and haemodialysis on dapsone elimination. Acta Med Scand 1983; 214: 215–220
   PubMed Web of Science ®Google Scholar
• Goldberg M J, Berlinger W G. Treatment of phenobarbital overdose with activated charcoal. JAMA 1982; 247: 2400–2401
   PubMed Web of Science ®Google Scholar
• Pond S M, Olson K R, Osterloh J D, Tong T G. Randomized study of the treatment of phenobarbital overdose with repeated doses of activated charcoal. JAMA 1984; 251: 3104–3108
   PubMed Web of Science ®Google Scholar
• Boldy D AR, Vale J A, Prescott L F. Treatment of phenobarbitone poisoning with repeated oral administration of activated charcoal. Q J Med 1986; 61: 997–1002
   PubMedGoogle Scholar
• Veerman M, Espejo M G, Christopher M A, Knight M. Use of activated charcoal to reduce elevated serum phenobarbital concentration in a neonate. J Toxicol Clin Toxicol 1991; 29: 53–58
   PubMed Web of Science ®Google Scholar
• Prescott L F, Hamilton A R, Heyworth R. Treatment of quinine overdosage with repeated oral charcoal. Br J Clin Pharmacol 1989; 27: 95–97
   PubMed Web of Science ®Google Scholar
• Amitai Y, Yeung A C, Moye J, Lovejoy F H. Repetitive oral activated charcoal and control of emesis in severe theophylline toxicity. Ann Intern Med 1986; 105: 386–387
   PubMed Web of Science ®Google Scholar
• Davis R, Ellsworth A, Justus R E, Bauer L A. Reversal of theophylline toxicity using oral activated charcoal. J Fam Pract 1985; 20: 73–74
   PubMed Web of Science ®Google Scholar
• Gal P, Miller A, McCue J D. Oral activated charcoal to enhance theophylline elimination in an acute overdose. JAMA 1984; 251: 3130–3131
   PubMed Web of Science ®Google Scholar
• Ohning B L, Reed M D, Blumer J L. Continuous nasogastric administration of activated charcoal for the treatment of theophylline intoxication. Pediatr Pharmacol 1986; 5: 241–245
   PubMedGoogle Scholar
• Sessler C N, Glauser F L, Cooper K R. Treatment of the ophylline toxicity with oral activated charcoal. Chest 1985; 87: 325–329
   PubMed Web of Science ®Google Scholar
• Shannon M, Amitai Y, Lovejoy F H, Jr. Multiple dose activated charcoal for theophylline poisoning in young infants. Pediatrics 1987; 80: 368–370
   PubMed Web of Science ®Google Scholar
• True R J, Berman J M, Mahutte C K. Treatment of theophylline toxicity with oral activated charcoal. Crit Care Med 1984; 12: 113–114
   PubMed Web of Science ®Google Scholar
• Hillman R J, Prescott L F. Treatment of salicylate poisoning with repeated oral charcoal. Br Med J 1985; 291: 1472
   PubMed Web of Science ®Google Scholar
• Vale J A. Methods to increase poison elimination. New Clinical Applications: Nephrology. Drugs and the Kidney, G RD Catto. Kluwer Academic Publishers, Lancaster 1990; 65–111
   Google Scholar
• Boldy D AR, Smart V, Vale J A. Multiple doses of charcoal in digoxin poisoning. Lancet 1985; 2: 1076–1077
   PubMed Web of Science ®Google Scholar
• Lake K D, Brown D C, Peterson C D. Digoxin toxicity: Enhanced systemic elimination during oral activated charcoal therapy. Pharmacotherapy 1984; 4: 161–163
   PubMed Web of Science ®Google Scholar
• Critchley JAJH, Critchley L AH. Digoxin toxicity in chronic renal failure: Treatment by multiple dose activated charcoal intestinal dialysis. Hum Exp Toxicol 1997; 16: 733–735
   PubMed Web of Science ®Google Scholar
• Ibanez C, Carcas A J, Frias J, Abad F. Activated charcoal increases digoxin elimination in patients. Int J Cardiol 1995; 48: 27–30
   PubMed Web of Science ®Google Scholar
• Pond S, Jacobs M, Marks J, Garner J, Goldschlager N, Hansen D. Treatment of digitoxin overdose with oral activated charcoal. Lancet 1981; 2: 1177–1178
   PubMed Web of Science ®Google Scholar
• Burkhart K K, Metcalf S, Shurnas E, et al. Exchange transfusion and multidose activated charcoal following vancomycin overdose. J Toxicol Clin Toxicol 1992; 30: 285–294
   PubMed Web of Science ®Google Scholar
• Kucukguclu S, Tuncok Y, Ozkan H, Guven H, Uguz A, Maltepe F. Mutliple-dose activated charcoal in an accidental vancomycin overdose. J Toxicol Clin Toxicol 1996; 34: 83–86
   PubMed Web of Science ®Google Scholar
• Hassan E. Treatment of meprobamate overdose with repeated oral doses of activated charcoal. Ann Emerg Med 1986; 15: 73–76
   PubMed Web of Science ®Google Scholar
• Linden C H, Rumack B H. Enhanced elimination of meprobamate by multiple doses of activated charcoal. Vet Hum Toxicol 1984; 26
   Google Scholar
• Gadgil S D, Damle S R, Advani S H, Vaidya A B. Effect of activated charcoal on the pharmacokinetics of high-dose methotrexate. Cancer Treat Rep 1982; 66: 1169–1171
   PubMedGoogle Scholar
• Griffiths M L, Kaplan H, Monteagudo F SE. Phenytoin overdose. S Afr Med J 1987; 71: 471
   PubMed Web of Science ®Google Scholar
• Howard C E, Roberts R S, Ely D S, Moye R A. Use of multiple-dose activated charcoal in phenytoin toxicity. Ann Pharmacother 1994; 28: 201–203
   PubMed Web of Science ®Google Scholar
• Ros S P, Black L E. Multiple-dose activated charcoal in management of phenytoin overdose. Pediatr Emerg Care 1989; 5: 169–170
   PubMedGoogle Scholar
• Weichbrodt G D, Elliott D P. Treatment of phenytoin toxicity with repeated doses of activated charcoal. Ann Emerg Med 1987; 6: 1387–1389
   Google Scholar
• Weidle P J, Skiest D J, Forrest A. Multiple-dose activated charcoal as adjunct therapy after chronic phenytoin intoxication. Clin Pharm 1991; 10: 711–714
   PubMedGoogle Scholar
• Swartz C M, Sherman A. The treatment of tricyclic antidepressant overdose with repeated charcoal. J Clin Psychopharmacol 1984; 4: 336–340
   PubMed Web of Science ®Google Scholar
• Ilett K F, Hackett L P, Dusci L J, Paterson J W. Disposition of dothiepin after overdose: Effects of repeated-dose activated charcoal. Ther Drug Monit 1991; 13: 485–489
   PubMed Web of Science ®Google Scholar
• Farrar H C, Herold D A, Reed M D. Acute valproic acid intoxication: Enhanced drug clearance with oral-activated charcoal. Crit Care Med 1993; 21: 299–301
   PubMed Web of Science ®Google Scholar
• Campbell J W, Chyka P A. Physicochemical characteristics of drugs and response to repeat-dose activated charcoal. Am J Emerg Med 1992; 10: 208–210
   PubMed Web of Science ®Google Scholar
• McKinnon R S, Desmond P V, Harman P J, et al. Studies on the mechanisms of action of activated charcoal on theophylline pharmacokinetics. J Pharm Pharmacol 1987; 39: 522–525
   PubMed Web of Science ®Google Scholar
• Levy G. Gastrointestinal clearance of drugs with activated charcoal. New Engl J Med 1982; 307: 676–678
   PubMed Web of Science ®Google Scholar
• Wakabayashi Y, Maruyama S, Hachimura K, Ohwada T. Activated charcoal interrupts enteroenteric circulation of phenobarbital. J Toxicol Clin Toxicol 1994; 32: 419–424
   PubMed Web of Science ®Google Scholar
• Kulig K W, Bar-Or D, Rumack B H. Intravenous theophylline poisoning and multiple-dose charcoal in an animal model. Ann Emerg Med 1987; 16: 842–846
   PubMed Web of Science ®Google Scholar
• Lim D T, Singh P, Nourtsis S, Cruz R D. Absorption inhibition and enhancement of elimination of sustained-release theophylline tablets by oral activated charcoal. Ann Emerg Med 1986; 15: 1303–1307
   PubMed Web of Science ®Google Scholar
• Minton N A, Henry J A. Prevention of drug absorption in simulated theophylline overdose. J Toxicol Clin Toxicol 1995; 33: 43–49
   PubMed Web of Science ®Google Scholar
• Goldberg M J, Spector R, Park G D, Johnson G F, Roberts P. The effect of sorbitol and activated charcoal on serum theophylline concentrations after slow-release theophylline. Clin Pharmacol Ther 1987; 41: 108–111
   PubMed Web of Science ®Google Scholar
• Hundt H KL, Aucamp A K, Muller F O. Pharmacokinetic aspects of carbamazepine and its two major metabolites in plasma during overdosage. Hum Toxicol 1983; 2: 607–614
   PubMedGoogle Scholar
• Vree T B, Janssen T J, Hekster Y A, Termond E FS, van de Dries A CP, Wijnands W JA. Clinical pharmacokinetics of carbamazepine and its epoxy and hydroxy metabolites in humans after an overdose. Ther Drug Monit 1986; 8: 297–304
   PubMed Web of Science ®Google Scholar
• Wason S, Baker R C, Carolan P, Seigel R, Druckenbrod R W. Carbamazepine overdose–The effects of multiple dose activated charcoal. J Toxicol Clin Toxicol 1992; 30: 39–48
   PubMed Web of Science ®Google Scholar
• Vale J A, Heath A. Carbamazepine overdose. J Toxicol Clin Toxicol 1992; 30: 481–482
   PubMed Web of Science ®Google Scholar
• Goodman and Gilman’s The Pharmacological Basis of Therapeutics, J G Hardman, L E Limbird, P B Molinoff, R W Ruddon, G A Gilman. 9th ed, McGraw-Hill, New York 1996; 1721
   Google Scholar
• Nilsson C, Sterner G, Idvall J. Charcoal hemoperfusion for treatment of serious carbamazepine poisoning. Acta Med Scand 1984; 216: 137–140
   PubMed Web of Science ®Google Scholar
• De Groot G, van Heijst A NP, Maes R AA. Charcoal hemoperfusion in the treatment of two cases of acute carbamazepine poisoning. J Toxicol Clin Toxicol 1984; 22: 349–362
   PubMed Web of Science ®Google Scholar
• Leslie P J, Heyworth R, Prescott L F. Cardiac complications of carbamazepine intoxication: Treatment by haemoperfusion. Br Med J 1983; 286: 1018
   PubMed Web of Science ®Google Scholar
• Lobo P I, Spyker D, Surratt P, Westervelt F B, Jr. Use of hemodialysis in meprobamate overdosage. Clin Nephrol 1977; 7: 73–75
   PubMed Web of Science ®Google Scholar
• Goldberg M J, Berlinger W G, Park G D. Activated charcoal in phenobarbital overdose. JAMA 1985; 253: 1120–1121
   PubMed Web of Science ®Google Scholar
• Pond S M, Osterloh J D, Olson K R, Tong T G. Activated charcoal in phenobarbital overdose. JAMA 1985; 253: 1121
   PubMed Web of Science ®Google Scholar
• Goodman and Gilman’s The Pharmacological Basis of Therapeutics, J G Hardman, L E Limbird, P B Molinoff, R W Ruddon, G A Gilman. 9th ed, McGraw-Hill, New York 1996; 1721
   Google Scholar
• Jacobsen D, Wiik-Larsen E, Dahl T, Enger E, Lunde P K. Pharmacokinetic evaluation of haemoperfusion in phenobarbital poisoning. Eur J Clin Pharmacol 1984; 26: 109–112
   PubMed Web of Science ®Google Scholar
• Verpooten G A, Heyndrickx, Zachee P, De Broe M E. Comparison of hemoperfusion and hemodialysis clearances during combined and prolonged treatment of severely poisoned patients. Mechanisms of Toxicity and Hazard Evaluation, B Holmstedt, R Lauwerys, M Mercier, M Roberfroid. 9th ed, Elsevier/North-Holland Biomedical Press, Amsterdam 1980; 411–414
   Google Scholar
• Vale J A. The medical management of acute poisoning: An evaluation of charcoal haemoperfusion MD Thesis. University of London. 1980
   Google Scholar
• Bateman D N, Blain P G, Woodhouse K W, et al. Pharmacokinetics and clinical toxicity of quinine overdosage: Lack of efficacy of techniques intended to enhance elimination. Q J Med 1985; 54: 125–131
   PubMedGoogle Scholar
• Dupuis R E, Lichtman S N, Pollack G M. Acute valproic acid overdose. Clinical course and pharmacokinetic disposition of valproic acid and metabolites. Drug Saf 1990; 5: 65–71
   PubMed Web of Science ®Google Scholar
• Ilkhanipour K, Yealy D M, Krenzelok E P. Activated charcoal surface area and its role in multiple-dose charcoal therapy. Am J Emerg Med 1993; 11: 583–585
   PubMed Web of Science ®Google Scholar
• Van de Graaff W B, Leigh Thompson W, Sunshine I, Fretthold D, Leickly F, Dayton H. Adsorbent and cathartic inhibition of enteral drug absorption. J Pharmacol Exp Ther 1982; 221: 656–663
   PubMed Web of Science ®Google Scholar
• Hunt J N, Stubbs D F. The volume and energy content of meals as determinants of gastric emptying. J Physiol 1975; 245: 209–225
   PubMed Web of Science ®Google Scholar
• Al-Shareef A H, Buss D C, Allen E M, Routledge P A. The effects of charcoal and sorbitol (alone and in combination) on plasma theophylline concentrations after a sustained-release formulation. Hum Exp Toxicol 1990; 9: 179–182
   PubMed Web of Science ®Google Scholar
• AACT/EAPCCT Position Statement: Cathartics. J Toxicol Clin Toxicol 1997; 35: 743–752
   PubMed Web of Science ®Google Scholar
• Watson W A, Cremer K F, Chapman J A. Gastrointestinal obstruction associated with multiple-dose activated charcoal. J Emerg Med 1986; 4: 401–407
   PubMedGoogle Scholar
• Ray M J, Padin D R, Condie J D, Halls J M, Charcoal bezoar. Small-bowel obstruction secondary to amitriptyline overdose therapy. Dig Dis Sci 1988; 33: 106–107
   PubMed Web of Science ®Google Scholar
• Atkinson S W, Young Y, Trotter G A. Treatment with activated charcoal complicated by gastrointestinal obstruction requiring surgery. Br Med J 1992; 305: 563
   PubMed Web of Science ®Google Scholar
• Mizutani T, Naito H, Oohashi N. Rectal ulcer with massive haemorrhage due to activated charcoal treatment in oral organophosphate poisoning. Hum Exe Toxicol 1991; 10: 385–386
   PubMed Web of Science ®Google Scholar
• Goulbourne K B, Cisek J E. Small-bowel obstruction secondary to activated charcoal and adhesions. Ann Emerg Med 1994; 24: 108–110
   PubMed Web of Science ®Google Scholar
• Gomez H F, Brent J A, Munoz D C, et al. Charcoal stercolith with intestinal perforation in a patient treated for amitriptyline ingestion. J Emerg Med 1994; 12: 57–60
   PubMedGoogle Scholar
• Menzies D G, Busuttil A, Prescott L F. Fatal pulmonary aspiration of oral activated charcoal. Br Med J 1988; 297: 459–460
   PubMed Web of Science ®Google Scholar
• Pollack M M, Dunbar B S, Holbrook RP., Fields AI. Aspiration of activated charcoal and gastric contents. Ann Emerg Med 1981; 10: 528–529
   PubMed Web of Science ®Google Scholar
• Harris C R, Filandrinos D. Accidental administration of activated charcoal into the lung: Aspiration by proxy. Ann Emerg Med 1993; 22: 1470–1473
   PubMed Web of Science ®Google Scholar
• Givens T, Holloway M, Wason S. Pulmonary aspiration of activated charcoal after tricyclic antidepressant overdose. Vet Hum Toxicol 1990; 32: 375
   Google Scholar
• Elliott C G, Colby T V, Kelly T M, Hicks H G, Charcoal H G. Bronchiolitis obliterans after aspiration of activated charcoal. Chest 1989; 96: 672–674
   PubMed Web of Science ®Google Scholar
• Benson B, VanAntwerp M, Hergott T. A fatality resulting from multiple dose activated charcoal therapy. Vet Hum Toxicol 1989; 31: 335
   Google Scholar
• Harsch H H. Aspiration of activated charcoal. N Engl J Med 1986; 314: 318
   PubMed Web of Science ®Google Scholar
• Rau N R, Nagaraj M V, Prakash P S, Nelli P. Fatal pulmonary aspiration of oral activated charcoal. Br Med J 1988; 297: 918–919
   Web of Science ®Google Scholar
• Allerton J P, Strom J A. Hypernatremia due to repeated doses of charcoal-sorbitol. Am J Kidney Dis 1991; 17: 581–584
   PubMed Web of Science ®Google Scholar
• Farley T A. Severe hypernatremic dehydration after use of an activated charcoal-sorbitol suspension. J Pediatr 1986; 109: 719–722
   PubMed Web of Science ®Google Scholar
• Gazda-Smith E, Synhavsky A. Hypernatremia follow-ing treatment of theophylline toxicity with activated char-coal and sorbitol. Arch Intern Med 1990; 150: 689–692
   PubMed Web of Science ®Google Scholar
• Garrelts J C, Watson W A, Holloway K D, Sweet D E. Magnesium toxicity secondary to catharsis during management of theophylline poisoning. Am J Emerg Med 1989; 7: 34–37
   PubMed Web of Science ®Google Scholar
• Weber C A, Santiago R M. Hypermagnesemia. A potential complication during treatment of theophylline intoxication with oral activated charcoal and magnesium-containing cathartics. Chest 1989; 95: 56–59
   PubMed Web of Science ®Google Scholar